Patient Guide: A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 164 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04895241
Status: ACTIVE_NOT_RECRUITING
Condition: Lupus Erythematosus, Systemic
Phase: PHASE3

Where You Can Participate

This study is available at 164 locations across the country.

Top locations include:
  • • Homewood, Alabama
  • • Beverly Hills, California
  • • Los Angeles, California
  • • And 161 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus - Join Clinical Trial NCTNCT04895241

How to Join This Clinical Trial - NCTNCT04895241

Learn how to participate in this PHASE3 trial studying an investigational therapy for Lupus Erythematosus, Systemic. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Lupus Erythematosus, Systemic. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Lupus Erythematosus, Systemic
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04895241 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 164 locations. Find a study site near you:

Clinical Research Site

Homewood, Alabama 35209 - United States

Status: Contact for availability

Clinical Research Site

Beverly Hills, California 90211 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90033 - United States

Status: Contact for availability

Clinical Research Site

Mission Hills, California 91345 - United States

Status: Contact for availability

Clinical Research Site

San Diego, California 92103 - United States

Status: Contact for availability

Clinical Research Site

Thousand Oaks, California 91360 - United States

Status: Contact for availability

Clinical Research Site

Torrance, California 90509 - United States

Status: Contact for availability

Clinical Research Site

Upland, California 91786 - United States

Status: Contact for availability

Clinical Research Site

Aurora, Colorado 80045 - United States

Status: Contact for availability

Clinical Research Site

Washington D.C., District of Columbia 20007-2113 - United States

Status: Contact for availability

And 154 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Lupus Erythematosus, Systemic:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships